Literature DB >> 35755540

A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma.

Zi W Goh1, Faisal Hasan2.   

Abstract

Hypophosphatemia can be commonly encountered as an electrolyte imbalance and is defined as a value less than 0.8 mmol/l (2.5 mg/dl). It can be an incidental finding, but it is not uncommon to see it presenting with varied symptoms. It is good to have a clear diagnostic approach to this so adequate treatment can be instated. We present a 66-year-old gentleman who presented with hypophosphatemia. Investigations confirmed renal phosphate wasting secondary to fibroblast growth factor-23 (FGF-23). Imaging showed right pleural effusion, and pleural biopsy confirmed malignant mesothelioma. This may just be an association rather than the cause of his hypophosphatemia. It does however highlight the importance of further investigations for patients with tumor-induced osteomalacia.
Copyright © 2022, Goh et al.

Entities:  

Keywords:  case report; fibroblast growth factor-23; hypophosphatemia; malignant mesothelioma; phosphate

Year:  2022        PMID: 35755540      PMCID: PMC9220217          DOI: 10.7759/cureus.25285

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

Review 1.  Approach to patients with hypophosphataemia.

Authors:  Pablo Florenzano; Cristiana Cipriani; Kelly L Roszko; Seiji Fukumoto; Michael T Collins; Salvatore Minisola; Jessica Pepe
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-07       Impact factor: 32.069

Review 2.  Hypophosphatemia: an evidence-based approach to its clinical consequences and management.

Authors:  Jamshid Amanzadeh; Robert F Reilly
Journal:  Nat Clin Pract Nephrol       Date:  2006-03

3.  Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm.

Authors:  Alvin Lee Day; Sarah L Morgan; Kenneth G Saag
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-06-15       Impact factor: 5.346

Review 4.  Phosphate homeostasis and disorders.

Authors:  P Manghat; R Sodi; R Swaminathan
Journal:  Ann Clin Biochem       Date:  2014-02-28       Impact factor: 2.057

5.  FGF23-Associated Tumor-Induced Osteomalacia in a Patient With Small Cell Carcinoma: A Case Report and Regulatory Mechanism Study.

Authors:  Adrienne Sauder; Szymon Wiernek; Xumin Dai; Renata Pereira; Michael Yudd; Charvi Patel; Andrew Golden; Shahida Ahmed; Jin Choe; Victor Chang; Slawomir Sender; Donghong Cai
Journal:  Int J Surg Pathol       Date:  2015-11-25       Impact factor: 1.271

6.  Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.

Authors:  Kanhaiyalal Agrawal; Sanjay Bhadada; Bhagwant Rai Mittal; Jaya Shukla; Ashwani Sood; Anish Bhattacharya; Anil Bhansali
Journal:  Clin Nucl Med       Date:  2015-01       Impact factor: 7.794

7.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.